Session » Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis

Date: Sunday, November 13, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 524

A Self-Determination Theory Based Intervention to Increase Levels of Cardiorespiratory Fitness, Self-Determined Motivation, Physical Activity and Improve Health Outcomes Among Patients Living with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 503

Anti-CCP Titer and Prevalence Is Influenced By Age at Rheumatoid Arthritis Onset- Analysis Based on a Nationwide Database in Japan

9:00AM-11:00AM: Abstract Number: 491

Anti-Citrullinated Peptide Antibodies Testing Rate over Time in Newly Diagnosed RA Patients – Data from Three Administrative Claims Databases (2007–2014)

9:00AM-11:00AM: Abstract Number: 512

Anti-Cyclic Citrullinated Protein Antibody (ACPA) Positivity in General Population and Follow-up Results for ACPA Positive Persons

9:00AM-11:00AM: Abstract Number: 528

Assessment of Metacarpal Head Bone Microarchitecture According to Presence or Not of Inflammation in Rheumatoid Arthritis Patients with Low Disease Activity

9:00AM-11:00AM: Abstract Number: 509

Association of Anti-Citrullinated Protein Antibody Positivity and Titer Levels to Low Hand BMD, and the Consequence of Low Hand BMD on DAS28 (CRP) Remission in Established RA: Findings from a US Observational Cohort

9:00AM-11:00AM: Abstract Number: 517

Association of Rheumatoid Arthritis Disease Activity and Clinical Profile with Chronic Periodontitis

9:00AM-11:00AM: Abstract Number: 508

Before Clinically Detectable Arthritis Develops, ACPA-Positive and ACPA-Negative Arthralgia Patients Have Different Symptoms

9:00AM-11:00AM: Abstract Number: 548

Body Mass Index Is Positively Correlated with Diverse Disease Activity Measures in Longstanding Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 546

Boolean-Based Remission in Rheumatoid Arthritis Using Physician Versus Patient Global Assessment: Differences in Ultrasonographic Disease Activities, Sustainabilities, and Relapse Rates

9:00AM-11:00AM: Abstract Number: 510

C-Reactive Protein and Disease Activity in Rheumatoid Arthritis: Impact of Obesity and Adiposity

9:00AM-11:00AM: Abstract Number: 492

Calprotectin Levels Correlate with Inflammation in Early Rheumatoid Arthritis before Disease-Modifying Antirheumatic Drug Treatment and after 12 Months of Treatment

9:00AM-11:00AM: Abstract Number: 500

Can Thiol/Disulphide Is a Novel Marker in Rheumatoid Arthritis?

9:00AM-11:00AM: Abstract Number: 551

Changes in Diverse Disease Activity Measures Are Highly Correlated Following the Initiation of Most Treatment Modalities in the Management of Longstanding Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 526

Changes in the Functional Status of the Rheumatoid Arthritis (RA) Population over the Biologic Era

9:00AM-11:00AM: Abstract Number: 542

Changes on Body Composition in Women with Long-Standing Established Rheumatoid Arthritis: Differences By Level of Disease Activity

9:00AM-11:00AM: Abstract Number: 554

Characteristics of Functional Impairment in Patients with Long-Standing Rheumatoid Arthritis Based on Range of Motion of Joints: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function

9:00AM-11:00AM: Abstract Number: 504

Clinical Significance of Multiple Autoantibody Specificities in Rheumatoid Arthritis: The Role of Anti-Citrullinated Alpha-Enolase and Anti-Interferon Inducible Protein 16 Antibodies

9:00AM-11:00AM: Abstract Number: 558

Clinical, Sonographic and Immunological Biomarkers of Ramris Progression in RA Patients in Clinical Remission: A Prospective Study with 12 Months of Follow-up

9:00AM-11:00AM: Abstract Number: 507

Comparison of Body Mass Index, Anti-Citrullinated Peptides Antibodies Status and Periodontal Condition in First Degree Relatives Individuals to Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 559

Comparison of Multi-Dimensional Health Assessment Questionnaire (MD-HAQ)-Based and Patient-Reported Outcomes Measurement Information System (PROMIS) 29-Based Routine Assessment of Patient Index 3 (RAPID3) for Assessing Rheumatoid Arthritis Disease Activity

9:00AM-11:00AM: Abstract Number: 511

Complement C3 and C4 Levels and Its Correlation with Disease Activity in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 547

Concordance Between Ultrasound Joint Synovitis and Clinical Joint Assessments By Patients or Physicians in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 518

Contribution of Patient Global Assessment on Loss and Gain of Disease Remission in Patients with Established Rheumatoid Arthritis in Clinical Practice

9:00AM-11:00AM: Abstract Number: 550

Despite Early Improvement and Limited Self-Reported Disability, Patients with Rheumatoid Arthritis Still Have Impaired Grip Strength 5 Years after Diagnosis

9:00AM-11:00AM: Abstract Number: 516

Development of RA Patient Preference Phenotypes

9:00AM-11:00AM: Abstract Number: 537

Differences and Associated Factors in General Disability and Hand Disability Between Patients with Rheumatoid Arthritis and Psoriatic Arthritis

9:00AM-11:00AM: Abstract Number: 557

Differences in Clinical Outcomes in Different Socio-Economic and Racial Groups with Rheumatoid Arthritis: Data from National Inpatient Sample

9:00AM-11:00AM: Abstract Number: 552

Disability in Early Rheumatoid Arthritis, Course and Predictors

9:00AM-11:00AM: Abstract Number: 534

Discordance Between Physician-Stated Remission and 28-Joint Disease Activity Score (DAS28)-Defined Remission in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 531

Disease Activity and Physical Fatigue As Related to Adherence and Health Literacy in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 562

Does Surgical Intervention to the Upper Extremity Make the Patients with Rheumatoid Arthritis Happy?

9:00AM-11:00AM: Abstract Number: 489

Early Detection of Inflammatory Arthritis: The Role of Musculoskeletal Symptoms, Infections and Rheumatoid Arthritis-Related Comorbidities in Primary Care

9:00AM-11:00AM: Abstract Number: 535

Examination of Diurnal and Daily Variation of the Multi-Biomarker Disease Activity (MBDA) Score in RA to Establish the Minimally Important Difference

9:00AM-11:00AM: Abstract Number: 488

Exploring the Association Between Air Pollutant Exposure and Seropositivity in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 490

First Report of Symptoms Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire

9:00AM-11:00AM: Abstract Number: 514

Gender Difference Is Apparent in the Risk of Forefoot Deformity in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 519

Greater Fatigue at Baseline and Female Gender Predict Worse Disability in Early RA Despite Treatment to Target: A Comparison of Two Observational Cohort Studies from the United Kingdom

9:00AM-11:00AM: Abstract Number: 555

HAQ Score Is an Independent Predictor of Sustained Remission in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 499

High Levels of Mir-451a Differentiate Patients at Risk of Developing RA from Healthy Controls

9:00AM-11:00AM: Abstract Number: 556

Higher Multi Biomarker Disease Activity Scores Foreshadow Greater Longitudinal Improvement in RA Disease Activity

9:00AM-11:00AM: Abstract Number: 498

Higher Serum Heavy Metals Concentrations Are Associated with Rheumatoid Arthritis : A Study of the Korean National Health and Nutrition Examination Survey (KNHANES)

9:00AM-11:00AM: Abstract Number: 496

Impact of Anti-Citrullinated Protein Antibody and/or Rheumatoid Factor on Rheumatoid Arthritis Manifestations and Outcomes

9:00AM-11:00AM: Abstract Number: 530

Importance of Functional and Utility Evaluation on Disease Activity Level in Rheumatoid Arthritis: Interrelations and Predictive Value

9:00AM-11:00AM: Abstract Number: 487

Limited Utility of Cytokine Profiles in Rheumatoid Arthritis Patients with Clinically Active Disease and Normal Inflammatory Indices

9:00AM-11:00AM: Abstract Number: 513

Low Serum 25-Hydroxyvitamin D Level Is Not Associated with Decreased Bone Mass or Bone Quality in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 523

Mortality Profile of Patients with Rheumatoid Arthritis in France and Its Change in 10 Years

9:00AM-11:00AM: Abstract Number: 541

Patient Goals in Rheumatoid Arthritis Care: A Literature Review

9:00AM-11:00AM: Abstract Number: 522

Patient-Provider Discordance in Global Assessments of Disease Activity in Patients with Rheumatoid Arthritis: Persistence, Predictors and Impact

9:00AM-11:00AM: Abstract Number: 544

Power Doppler Ultrasound Signal Associates with Abnormal HDL Function and Suppression of Paraoxonase 1 Activity in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 536

Precision Medicine in Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis on the Diagnostic Accuracy of Anti-CCP Tests for the Diagnosis of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 525

Predictors of Health Care Drop-out in an Inception Cohort of Patients with Early Onset Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 539

Promis Short Forms Are Relevant to People Living with RA: Results of Cognitive Debriefing Interviews

9:00AM-11:00AM: Abstract Number: 494

Sensitivity and Specificity of 14-3-3η, Anti-CEP-1 and Anti-Sa Antibodies in a Cohort of Seronegative and Suspected Rheumatoid Arthritis (RA) Patients from a Community Rheumatology Practice

9:00AM-11:00AM: Abstract Number: 561

Sodium Intake Is Increased in Patients with Early Rheumatoid Arthritis and Is Associated with Radiographic Erosions

9:00AM-11:00AM: Abstract Number: 521

Subcutaneous Adipose Tissue from Rheumatoid Arthritis Patients Is Characterized By an Abundance of Macrophages That Are Associated with Autoantibodies, Systemic Inflammation, and Immunomodulation

9:00AM-11:00AM: Abstract Number: 543

Synovial Features of Rheumatoid Arthritis and Psoriatic Arthritis Differ in Patients in Clinical and Ultrasound Remission after Anti-TNF Therapy

9:00AM-11:00AM: Abstract Number: 493

The 2010 ACR/EULAR Criteria Are Not Sufficiently Accurate in the Early Identification of Autoantibody-Negative Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 515

The Association of Body Mass Index with the Severity of Magnetic Resonance Imaging-Detected Inflammation at Presentation; Opposite Effects in Early Rheumatoid Arthritis Compared to Other Arthritides and an Asymptomatic Population

9:00AM-11:00AM: Abstract Number: 532

The DAS28 Score May Misread Disease Activity in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 520

The HAQ Reversible and Irreversible Components Measuring Function in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 497

The Identification of an ACR Score with the Optimal Discriminatory Ability Between Treatments in Patients with Early and Established Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 540

The Importance of Outcome Measures in Rheumatoid Arthritis – Validity of the Routine Assessment of Patient Index Data 3 in a Real World Setting

9:00AM-11:00AM: Abstract Number: 505

The Longitudinal Stability of the RA Biomarkers RF and ACPA in Classifying RA Subtypes over Extended Follow up

9:00AM-11:00AM: Abstract Number: 506

The Relationship Between Elevations in CRP with Physical Function and Radiographic Progression over the Long-Term in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 529

The Relationship Between Promis and CDAI Scores, Disease Duration, Age and Gender in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 495

The Relative Performance of 28-Joint Disease Activity Score Based on C-Reactive Protein with Three Versus Four Components in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 527

The Summed Bilateral Elbow Extension Angle in Rheumatoid Arthritis Correlates with the DAS28-CRP(4) and May be an Independent Marker of Bad Prognosis

9:00AM-11:00AM: Abstract Number: 560

There Is No Further Gain from Calculating Disease Activity Score in 28 Joints with High Sensitivity Assays of C-Reactive Protein Because of High Intraindividual Variability of CRP: A Cross Sectional Study and Theoretical Consideration

9:00AM-11:00AM: Abstract Number: 501

Use of Rheumatologic Testing By Primary Care Physicians in Patients with Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 502

Use, Usability and Feasibility of a Mapp for Patients with Rheumatoid Arthritis – First Results

9:00AM-11:00AM: Abstract Number: 545

Utility of Power Doppler Ultrasound-Detected Synovitis for the Prediction of Short Term Flare in Rheumatoid Arthritis Patients in Clinical Remission

9:00AM-11:00AM: Abstract Number: 553

Validation of Index of Activity Speed (Timed Up and Go test) for Outcome Measure of Patients with Long-Standing Rheumatoid Arthritis: Multicenter Prospective Cohort Study for Evaluation of Joint Surgery on Physical Function

9:00AM-11:00AM: Abstract Number: 538

What Is the Relationship Between Early Metacarpophalangeal Erosions on MRI and Joint Pain in Rheumatoid Arthritis?

9:00AM-11:00AM: Abstract Number: 533

What Proportion of Patients Fail to Achieve CDAI and SDAI Remission Based on Physician Global Assessment? an Analysis from the Prospective, Observational Registry

9:00AM-11:00AM: Abstract Number: 549

Work Status in Patients with Rheumatoid Arthritis Who Have Poor Prognostic Factors: Findings from a US Observational Cohort

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].